Clinical trial / 2013
Daily β-glucan supplementation for 4 weeks reduced allergy symptoms and improved quality of life in ragweed allergy sufferers.
In a double-blind trial, 48 adults with self-described moderate ragweed allergy were randomized to receive 250 mg/day of Wellmune WGP β-1,3/1,6-Glucan (n=24) or placebo (n=24) for 4 weeks during ragweed season. Compared with placebo, β-glucan reduced total allergy symptoms (28%), symptom severity (52%), and VAS symptom rating (37%) (P < 0.05), but had no effect on serum IgE levels. The supplement also improved mood attributes on the POMS (e.g., 45% reduction in depression, 38% reduction in fatigue), increased physical health (11%) and energy (19%) on the SF-36, and improved quality of life by 56% on the RQLQ.
- Study type
- Randomized, placebo-controlled, double-blind trial
- Who was studied
- 48 self-described "moderate" ragweed allergy sufferers (mean age 36 ± 9 years)
- What was measured
- Allergy symptoms, serum IgE, psychological well-being (POMS), physical function (RAND SF-36), and quality of life (RQLQ)
THE PAPER
β-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.
Talbott SM, Talbott JA, Talbott TL, Dingler E. Food Sci Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.